Molecular Templates Inc Share Price (NASDAQ: MTEM)

▲

-0.03

(-100%)

Last updated on January 6, 2025 at 12:00 am IST

$₹

The stock has been delisted from the stock exchange on 6 Jan 2025

Check the interactive Molecular Templates Inc Stock chart to analyse performance

Molecular Templates Inc Key Stats

Check Molecular Templates Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.03
Open	$0.03
Market Capitalization	$199.5K
Today's Volume	$123.6K
Revenue TTM	$25.5M
EBITDA	$-13.9M
Earnings Per Share (EPS)	$-3.05
Profit Margin	-61.35%
Quarterly Earnings Growth YOY	-0.97%
Return On Equity TTM	-929.14%

Global Institutional Holdings in Molecular Templates Inc

Name
Holdings %
Name
Holdings %
Bellevue Group AG
19.44%
SILVERARC CAPITAL MANAGEMENT, LLC
9.48%
Bvf Inc
7.93%
Bank of Montreal
1.11%
BMO Capital Markets Corp.
1.11%
Vanguard Group Inc
0.77%

Analyst Recommendation on Molecular Templates Inc Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Molecular Templates Inc(by analysts ranked 0 to 5 stars)

Molecular Templates Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY18

FY19

FY20

FY21

FY22

FY23

	FY18	Y/Y Change
Revenue	$7.3M	↑ 202.45%
Net Income	$-30.3M	↑ 30.89%
Net Profit Margin	-415.86%	↑ 545.1%

	FY19	Y/Y Change
Revenue	$19.5M	↑ 167.73%
Net Income	$-69.5M	↑ 129.59%
Net Profit Margin	-356.62%	↑ 59.24%

	FY20	Y/Y Change
Revenue	$18.8M	↓ 3.35%
Net Income	$104.9M	↓ 250.88%
Net Profit Margin	556.73%	↑ 913.35%

	FY21	Y/Y Change
Revenue	$38.7M	↑ 105.34%
Net Income	$-79.3M	↓ 175.6%
Net Profit Margin	-204.96%	↓ 761.69%

	FY22	Y/Y Change
Revenue	$19.8M	↓ 48.95%
Net Income	$-92.7M	↑ 16.9%
Net Profit Margin	-469.36%	↓ 264.4%

	FY23	Y/Y Change
Revenue	$57.3M	↑ 190.1%
Net Income	$-8.1M	↓ 91.24%
Net Profit Margin	-14.18%	↑ 455.18%

Q1 FY23

Q2 FY23

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

	Q1 FY23	Q/Q Change
Revenue	$33.6M	↑ 1187.9%
Net Income	$8.5M	↓ 138.6%
Net Profit Margin	25.31%	↑ 869.78%

	Q2 FY23	Q/Q Change
Revenue	$6.6M	↓ 80.29%
Net Income	$-10.9M	↓ 227.71%
Net Profit Margin	-164.0%	↓ 189.31%

	Q3 FY23	Q/Q Change
Revenue	$6.8M	↑ 2.55%
Net Income	$4.2M	↓ 138.21%
Net Profit Margin	61.11%	↑ 225.11%

	Q4 FY23	Q/Q Change
Revenue	$7.0M	↑ 3.24%
Net Income	$-3.9M	↓ 195.06%
Net Profit Margin	-56.27%	↓ 117.38%

	Q1 FY24	Q/Q Change
Revenue	$11.1M	↑ 58.01%
Net Income	$572.0K	↓ 114.49%
Net Profit Margin	5.16%	↑ 61.43%

	Q2 FY24	Q/Q Change
Revenue	$572.0K	↓ 94.84%
Net Income	$-8.1M	↓ 1515.56%
Net Profit Margin	-1.4K%	↓ 1420.72%

FY18

FY19

FY20

FY21

FY22

FY23

	FY18	Y/Y Change
Profit	$-22.9M	↓ 1051.79%

	FY19	Y/Y Change
Profit	$-31.0M	↑ 35.35%

	FY20	Y/Y Change
Profit	$18.8M	↓ 160.75%

	FY21	Y/Y Change
Profit	$38.7M	↑ 105.34%

	FY22	Y/Y Change
Profit	$12.0M	↓ 69.11%

	FY23	Y/Y Change
Profit	$50.4M	↑ 321.57%

Q1 FY23

Q2 FY23

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

	Q1 FY23	Q/Q Change
Profit	$14.6M	↑ 2754.21%

	Q2 FY23	Q/Q Change
Profit	$-6.8M	↓ 146.53%

	Q3 FY23	Q/Q Change
Profit	$5.3M	↓ 178.04%

	Q4 FY23	Q/Q Change
Profit	$5.7M	↑ 8.27%

	Q1 FY24	Q/Q Change
Profit	$9.9M	↑ 73.26%

	Q2 FY24	Q/Q Change
Profit	$-4.8M	↓ 148.62%

FY18

FY19

FY20

FY21

FY22

	FY18	Y/Y Change
Operating Cash Flow	$-4.5M	↓ 68.7%
Investing Cash Flow	$-15.9M	↓ 264.13%
Financing Cash Flow	$49.2M	↓ 20.28%

	FY19	Y/Y Change
Operating Cash Flow	$-25.2M	↑ 465.38%
Investing Cash Flow	$-39.7M	↑ 149.13%
Financing Cash Flow	$65.7M	↑ 33.48%

	FY20	Y/Y Change
Operating Cash Flow	$-83.8M	↑ 231.95%
Investing Cash Flow	$-34.7M	↓ 12.74%
Financing Cash Flow	$58.9M	↓ 10.35%

	FY21	Y/Y Change
Operating Cash Flow	$-30.4M	↓ 63.74%
Investing Cash Flow	$-62.4M	↑ 80.13%
Financing Cash Flow	$92.6M	↑ 57.22%

	FY22	Y/Y Change
Operating Cash Flow	$-89.0M	↑ 192.97%
Investing Cash Flow	$95.3M	↓ 252.65%
Financing Cash Flow	$-265.0K	↓ 100.29%

Q1 FY23

Q2 FY23

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-19.4M	↑ 5.04%
Investing Cash Flow	$26.0M	↓ 8.44%
Financing Cash Flow	$-27.5M	↑ 9936.5%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-9.6M	↓ 50.22%
Investing Cash Flow	$3.1M	↓ 87.92%
Financing Cash Flow	$-27.5M	↑ 0.0%

About Molecular Templates Inc

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.

Organization	Molecular Templates Inc
Employees	62
CEO	Dr. Eric E. Poma Ph.D.
Industry	Health Technology

Key Management of Molecular Templates Inc

Name	Title
Dr. Eric E. Poma Ph.D.	Interim CFO, Treasurer, Principal Acc. Officer, CEO, Chief Scientific Officer & Director
Ms. Kristen Quigley B.A.	Chief Operating Officer
Dr. Grace Kim	Chief Strategy Officer & Head of IR
Dr. Michelle Iwamoto-Fan J.D., Ph.D.	Senior Vice President & General Counsel
Dr. Joseph Phillips Ph.D.	Senior VP & Head of CMC Development
Dr. Chris Moore Ph.D.	Senior VP and Head of Preclinical Development & Translational Medicine

Important FAQs about investing in MTEM Stock from India :

What is Molecular Templates Inc share price today?

Molecular Templates Inc share price today is as on January 6, 2025 at 12:00 am IST at the close of the market. Molecular Templates Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Molecular Templates Inc share?

Molecular Templates Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Molecular Templates Inc stock price today i.e. January 6, 2025 at 12:00 am IST is closed at , lower by 100% versus the 52 week high.

How to invest in Molecular Templates Inc Stock (MTEM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Molecular Templates Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Molecular Templates Inc Shares .

What is the minimum amount required to buy Molecular Templates Inc Stock (MTEM) from India?

Indian investors can start investing in Molecular Templates Inc (MTEM) shares with as little as ₹88.2013 or $1 (as of September 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.01 in Molecular Templates Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025). Learn more about fractional shares .

What are the returns that Molecular Templates Inc has given to Indian investors in the last 5 years?

Molecular Templates Inc stock has given 0.0% share price returns and 19.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?

Discover More

Prairie Operating Co. Common Stock
$2.08
-1.89%
Global X S&p 500 Tail Risk Etf
$30.14
+0.37%
Paychex, Inc.
$131.97
-2.32%
Defiance S&p 500 Target Income Etf
$18.29
+0.16%
First Hawaiian, Inc.
$25.40
-0.66%
Pimco Etf Trust Pimco Mortgage-backed Securities Active Exchange-traded Fund
$49.94
+0.28%
Nyli Mackay Municipal Insured Etf
$23.80
+0.34%
Vertical Aerospace Ltd
$5.37
+1.13%
Estrella Immunopharma Inc
$1.05
+0.0%

Explore all